Efungumab

Tidak ditemukan merek terdaftar untuk zat aktif ini.

Tidak ada catatan makanan tercatat untuk zat aktif ini.

• AbagovomabMODERAT

  Mengonsumsi Abagovomab bersama Efungumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Abagovomab is combined with Efungumab.

• AbciximabMODERAT

  Mengonsumsi Abciximab bersama Efungumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Abciximab is combined with Efungumab.

• AbituzumabMODERAT

  Mengonsumsi Abituzumab bersama Efungumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Abituzumab is combined with Efungumab.

• AbrilumabMODERAT

  Mengonsumsi Abrilumab bersama Efungumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Abrilumab is combined with Efungumab.

• AdalimumabMODERAT

  Mengonsumsi Adalimumab bersama Efungumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Adalimumab is combined with Efungumab.

• AdecatumumabMODERAT

  Mengonsumsi Adecatumumab bersama Efungumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Adecatumumab is combined with Efungumab.

• AducanumabMODERAT

  Mengonsumsi Aducanumab bersama Efungumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Aducanumab is combined with Efungumab.

• AfelimomabMODERAT

  Mengonsumsi Afelimomab bersama Efungumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Afelimomab is combined with Efungumab.

• AlemtuzumabMODERAT

  Mengonsumsi Alemtuzumab bersama Efungumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Efungumab.

• AlirocumabMODERAT

  Mengonsumsi Alirocumab bersama Efungumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Alirocumab is combined with Efungumab.